Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Common Mechanisms of Viral Injury to the Kidney.

Bruggeman LA.

Adv Chronic Kidney Dis. 2019 May;26(3):164-170. doi: 10.1053/j.ackd.2018.12.002. Review.

PMID:
31202388
2.

APOL1 polymorphisms and kidney disease: loss-of-function or gain-of-function?

Bruggeman LA, O'Toole JF, Sedor JR.

Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F1-F8. doi: 10.1152/ajprenal.00426.2018. Epub 2018 Oct 17.

PMID:
30332315
3.

Similar Biophysical Abnormalities in Glomeruli and Podocytes from Two Distinct Models.

Embry AE, Liu Z, Henderson JM, Byfield FJ, Liu L, Yoon J, Wu Z, Cruz K, Moradi S, Gillombardo CB, Hussain RZ, Doelger R, Stuve O, Chang AN, Janmey PA, Bruggeman LA, Miller RT.

J Am Soc Nephrol. 2018 May;29(5):1501-1512. doi: 10.1681/ASN.2017050475. Epub 2018 Mar 23.

4.

Fyn-binding protein ADAP supports actin organization in podocytes.

Wu Z, Blessing NA, Simske JS, Bruggeman LA.

Physiol Rep. 2017 Dec;5(23). doi: 10.14814/phy2.13483.

5.

ApoL1 Overexpression Drives Variant-Independent Cytotoxicity.

O'Toole JF, Schilling W, Kunze D, Madhavan SM, Konieczkowski M, Gu Y, Luo L, Wu Z, Bruggeman LA, Sedor JR.

J Am Soc Nephrol. 2018 Mar;29(3):869-879. doi: 10.1681/ASN.2016121322. Epub 2017 Nov 27.

6.

The Cell Biology of APOL1.

O'Toole JF, Bruggeman LA, Madhavan S, Sedor JR.

Semin Nephrol. 2017 Nov;37(6):538-545. doi: 10.1016/j.semnephrol.2017.07.007. Review.

7.

APOL1 and Proteinuria in the AASK: Unraveling the Pathobiology of APOL1.

O'Toole JF, Bruggeman LA, Sedor JR.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1723-1725. doi: 10.2215/CJN.10680917. Epub 2017 Oct 19. No abstract available.

8.

A New Mouse Model of APOL1-Associated Kidney Diseases: When Traffic Gets Snarled, the Podocyte Suffers.

O'Toole JF, Bruggeman LA, Sedor JR.

Am J Kidney Dis. 2017 Oct;70(4):460-463. doi: 10.1053/j.ajkd.2017.07.002. Epub 2017 Aug 9. No abstract available.

PMID:
28801123
9.

APOL1 variants change C-terminal conformational dynamics and binding to SNARE protein VAMP8.

Madhavan SM, O'Toole JF, Konieczkowski M, Barisoni L, Thomas DB, Ganesan S, Bruggeman LA, Buck M, Sedor JR.

JCI Insight. 2017 Jul 20;2(14). pii: 92581. doi: 10.1172/jci.insight.92581. eCollection 2017 Jul 20.

10.

Identifying the Intracellular Function of APOL1.

Bruggeman LA, O'Toole JF, Sedor JR.

J Am Soc Nephrol. 2017 Apr;28(4):1008-1011. doi: 10.1681/ASN.2016111262. Epub 2017 Feb 14. No abstract available.

11.

HIV-1 Infection of Renal Cells in HIV-Associated Nephropathy.

Bruggeman LA.

J Am Soc Nephrol. 2017 Mar;28(3):719-721. doi: 10.1681/ASN.2016111171. Epub 2017 Jan 9. No abstract available.

12.

Biochemical and Cellular Determinants of Renal Glomerular Elasticity.

Embry AE, Mohammadi H, Niu X, Liu L, Moe B, Miller-Little WA, Lu CY, Bruggeman LA, McCulloch CA, Janmey PA, Miller RT.

PLoS One. 2016 Dec 12;11(12):e0167924. doi: 10.1371/journal.pone.0167924. eCollection 2016.

13.

APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.

Bruggeman LA, Wu Z, Luo L, Madhavan SM, Konieczkowski M, Drawz PE, Thomas DB, Barisoni L, Sedor JR, O'Toole JF.

J Am Soc Nephrol. 2016 Dec;27(12):3600-3610. Epub 2016 Mar 29.

14.

α-Actinin 4 potentiates nuclear factor κ-light-chain-enhancer of activated B-cell (NF-κB) activity in podocytes independent of its cytoplasmic actin binding function.

Zhao X, Hsu KS, Lim JH, Bruggeman LA, Kao HY.

J Biol Chem. 2015 Jan 2;290(1):338-49. doi: 10.1074/jbc.M114.597260. Epub 2014 Nov 19.

15.

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.

Lucas GM, Ross MJ, Stock PG, Shlipak MG, Wyatt CM, Gupta SK, Atta MG, Wools-Kaloustian KK, Pham PA, Bruggeman LA, Lennox JL, Ray PE, Kalayjian RC; HIV Medicine Association of the Infectious Diseases Society of America.

Clin Infect Dis. 2014 Nov 1;59(9):e96-138. doi: 10.1093/cid/ciu617. Epub 2014 Sep 17.

16.

Assaying NF-κB activation and signaling from TNF receptors.

Wu Z, Bruggeman LA.

Methods Mol Biol. 2014;1155:1-14. doi: 10.1007/978-1-4939-0669-7_1.

PMID:
24788168
17.

Plasma apolipoprotein L1 levels do not correlate with CKD.

Bruggeman LA, O'Toole JF, Ross MD, Madhavan SM, Smurzynski M, Wu K, Bosch RJ, Gupta S, Pollak MR, Sedor JR, Kalayjian RC.

J Am Soc Nephrol. 2014 Mar;25(3):634-44. doi: 10.1681/ASN.2013070700. Epub 2013 Nov 14.

18.

Microarray analyses of glucocorticoid and vitamin D3 target genes in differentiating cultured human podocytes.

Cheng X, Zhao X, Khurana S, Bruggeman LA, Kao HY.

PLoS One. 2013 Apr 4;8(4):e60213. doi: 10.1371/journal.pone.0060213. Print 2013. Erratum in: PLoS One. 2013;8(6). doi:10.1371/annotation/ce9027f6-dbf9-4fc9-af40-9e244edf6a6e.

19.

A cell culture system for the structure and hydrogel properties of basement membranes; Application to capillary walls.

Bruggeman LA, Doan RP, Loftis J, Darr A, Calabro A.

Cell Mol Bioeng. 2012 Jun 1;5(2):194-204. Epub 2012 Feb 8.

20.

Nuclear hormone receptors in podocytes.

Khurana S, Bruggeman LA, Kao HY.

Cell Biosci. 2012 Sep 20;2(1):33. doi: 10.1186/2045-3701-2-33.

21.

Shear stress induces cell apoptosis via a c-Src-phospholipase D-mTOR signaling pathway in cultured podocytes.

Huang C, Bruggeman LA, Hydo LM, Miller RT.

Exp Cell Res. 2012 Jun 10;318(10):1075-85. doi: 10.1016/j.yexcr.2012.03.011. Epub 2012 Mar 26.

22.

Familial focal segmental glomerulosclerosis (FSGS)-linked α-actinin 4 (ACTN4) protein mutants lose ability to activate transcription by nuclear hormone receptors.

Khurana S, Chakraborty S, Lam M, Liu Y, Su YT, Zhao X, Saleem MA, Mathieson PW, Bruggeman LA, Kao HY.

J Biol Chem. 2012 Apr 6;287(15):12027-35. doi: 10.1074/jbc.M112.345421. Epub 2012 Feb 17.

23.

APOL1 localization in normal kidney and nondiabetic kidney disease.

Madhavan SM, O'Toole JF, Konieczkowski M, Ganesan S, Bruggeman LA, Sedor JR.

J Am Soc Nephrol. 2011 Nov;22(11):2119-28. doi: 10.1681/ASN.2011010069. Epub 2011 Oct 13.

24.

TM4SF10 and ADAP interaction in podocytes: role in Fyn activity and nephrin phosphorylation.

Azhibekov TA, Wu Z, Padiyar A, Bruggeman LA, Simske JS.

Am J Physiol Cell Physiol. 2011 Dec;301(6):C1351-9. doi: 10.1152/ajpcell.00166.2011. Epub 2011 Aug 31.

25.

Identification of the nephropathy-susceptibility locus HIVAN4.

Prakash S, Papeta N, Sterken R, Zheng Z, Thomas RL, Wu Z, Sedor JR, D'Agati VD, Bruggeman LA, Gharavi AG.

J Am Soc Nephrol. 2011 Aug;22(8):1497-504. doi: 10.1681/ASN.2011020209. Epub 2011 Jul 22.

26.

TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α.

Bruggeman LA, Drawz PE, Kahoud N, Lin K, Barisoni L, Nelson PJ.

Lab Invest. 2011 Mar;91(3):413-25. doi: 10.1038/labinvest.2010.199. Epub 2011 Jan 10.

27.

Biophysical properties of normal and diseased renal glomeruli.

Wyss HM, Henderson JM, Byfield FJ, Bruggeman LA, Ding Y, Huang C, Suh JH, Franke T, Mele E, Pollak MR, Miner JH, Janmey PA, Weitz DA, Miller RT.

Am J Physiol Cell Physiol. 2011 Mar;300(3):C397-405. doi: 10.1152/ajpcell.00438.2010. Epub 2010 Dec 1.

28.

Podocyte injury induces nuclear translocation of WTIP via microtubule-dependent transport.

Kim JH, Konieczkowski M, Mukherjee A, Schechtman S, Khan S, Schelling JR, Ross MD, Bruggeman LA, Sedor JR.

J Biol Chem. 2010 Mar 26;285(13):9995-10004. doi: 10.1074/jbc.M109.061671. Epub 2010 Jan 10.

29.

HIV and the Kidney.

Bruggeman LA, Bark C, Kalayjian RC.

Curr Infect Dis Rep. 2009 Nov;11(6):479-85.

30.

Controversies in the pathogenesis of HIV-associated renal diseases.

Bruggeman LA, Nelson PJ.

Nat Rev Nephrol. 2009 Oct;5(10):574-81. doi: 10.1038/nrneph.2009.139. Review.

31.

Insight versus Quagmire with compound HIV transgenics.

Bruggeman LA.

J Am Soc Nephrol. 2009 Oct;20(10):2085-6. doi: 10.1681/ASN.2009080811. Epub 2009 Sep 3. No abstract available.

32.

Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression.

Papeta N, Chan KT, Prakash S, Martino J, Kiryluk K, Ballard D, Bruggeman LA, Frankel R, Zheng Z, Klotman PE, Zhao H, D'Agati VD, Lifton RP, Gharavi AG.

J Clin Invest. 2009 May;119(5):1178-88. doi: 10.1172/JCI37131. Epub 2009 Apr 20.

33.

Collapsing glomerulopathy: beyond serendipity in mouse genetics.

Nelson PJ, Bruggeman LA.

Kidney Int. 2009 Feb;75(4):353-5. doi: 10.1038/ki.2008.554.

34.

Viral subversion mechanisms in chronic kidney disease pathogenesis.

Bruggeman LA.

Clin J Am Soc Nephrol. 2007 Jul;2 Suppl 1:S13-9. Review.

35.
36.

HIV infection changes glomerular podocyte cytoskeletal composition and results in distinct cellular mechanical properties.

Tandon R, Levental I, Huang C, Byfield FJ, Ziembicki J, Schelling JR, Bruggeman LA, Sedor JR, Janmey PA, Miller RT.

Am J Physiol Renal Physiol. 2007 Feb;292(2):F701-10. Epub 2006 Oct 17.

37.

Math6 expression during kidney development and altered expression in a mouse model of glomerulosclerosis.

Ross MD, Martinka S, Mukherjee A, Sedor JR, Vinson C, Bruggeman LA.

Dev Dyn. 2006 Nov;235(11):3102-9.

38.

Beta8 integrin binds Rho GDP dissociation inhibitor-1 and activates Rac1 to inhibit mesangial cell myofibroblast differentiation.

Lakhe-Reddy S, Khan S, Konieczkowski M, Jarad G, Wu KL, Reichardt LF, Takai Y, Bruggeman LA, Wang B, Sedor JR, Schelling JR.

J Biol Chem. 2006 Jul 14;281(28):19688-99. Epub 2006 May 11.

39.

Detection and localization of HIV-1 DNA in renal tissues by in situ polymerase chain reaction.

Tanji N, Ross MD, Tanji K, Bruggeman LA, Markowitz GS, Klotman PE, D'Agati VD.

Histol Histopathol. 2006 Apr;21(4):393-401. doi: 10.14670/HH-21.393.

PMID:
16437385
40.

Persistent NF-kappaB activation in renal epithelial cells in a mouse model of HIV-associated nephropathy.

Martinka S, Bruggeman LA.

Am J Physiol Renal Physiol. 2006 Mar;290(3):F657-65. Epub 2005 Oct 4.

41.

NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy.

Ross MJ, Martinka S, D'Agati VD, Bruggeman LA.

J Am Soc Nephrol. 2005 Aug;16(8):2403-11. Epub 2005 Jun 23.

42.

WT1-interacting protein and ZO-1 translocate into podocyte nuclei after puromycin aminonucleoside treatment.

Rico M, Mukherjee A, Konieczkowski M, Bruggeman LA, Miller RT, Khan S, Schelling JR, Sedor JR.

Am J Physiol Renal Physiol. 2005 Aug;289(2):F431-41. Epub 2005 Mar 29.

43.

Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3.

Gharavi AG, Ahmad T, Wong RD, Hooshyar R, Vaughn J, Oller S, Frankel RZ, Bruggeman LA, D'Agati VD, Klotman PE, Lifton RP.

Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2488-93.

44.

A WT1 co-regulator controls podocyte phenotype by shuttling between adhesion structures and nucleus.

Srichai MB, Konieczkowski M, Padiyar A, Konieczkowski DJ, Mukherjee A, Hayden PS, Kamat S, El-Meanawy MA, Khan S, Mundel P, Lee SB, Bruggeman LA, Schelling JR, Sedor JR.

J Biol Chem. 2004 Apr 2;279(14):14398-408. Epub 2004 Jan 20.

45.

EphA kinase activation regulates HGF-induced epithelial branching morphogenesis.

Miao H, Nickel CH, Cantley LG, Bruggeman LA, Bennardo LN, Wang B.

J Cell Biol. 2003 Sep 29;162(7):1281-92.

46.

Applications of gene therapy to kidney disease.

Hanss B, Bruggeman LA.

Curr Opin Nephrol Hypertens. 2003 Jul;12(4):439-45. Review.

PMID:
12815341
47.

Podocan, a novel small leucine-rich repeat protein expressed in the sclerotic glomerular lesion of experimental HIV-associated nephropathy.

Ross MD, Bruggeman LA, Hanss B, Sunamoto M, Marras D, Klotman ME, Klotman PE.

J Biol Chem. 2003 Aug 29;278(35):33248-55. Epub 2003 Jun 8.

48.

Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy.

Marras D, Bruggeman LA, Gao F, Tanji N, Mansukhani MM, Cara A, Ross MD, Gusella GL, Benson G, D'Agati VD, Hahn BH, Klotman ME, Klotman PE.

Nat Med. 2002 May;8(5):522-6.

PMID:
11984599
49.

Effect of target cell availability on HIV-1 production in vitro.

Schwartz EJ, Neumann AU, Teixeira AV, Bruggeman LA, Rappaport J, Perelson AS, Klotman PE.

AIDS. 2002 Feb 15;16(3):341-5.

PMID:
11834944
50.

Microcyst formation and HIV-1 gene expression occur in multiple nephron segments in HIV-associated nephropathy.

Ross MJ, Bruggeman LA, Wilson PD, Klotman PE.

J Am Soc Nephrol. 2001 Dec;12(12):2645-51.

Supplemental Content

Loading ...
Support Center